Archive for the ‘Media Control’ Category

Not wearing masks to protect against coronavirus is a ‘big mistake,’ top Chinese scientist says – Science Magazine

In Wuhan, China, people with mild COVID-19 cases were taken to large facilities and not permitted to see their families. Infected people must be isolated. That should happen everywhere, George Gao says.

By Jon CohenMar. 27, 2020 , 6:15 PM

Sciences COVID-19 reporting is supported by the Pulitzer Center.

Chinese scientists at the front of that countrys outbreak of coronavirus disease 2019 (COVID-19) have not been particularly accessible to foreign media. Many have been overwhelmed trying to understand their epidemic and combat it, and responding to media requests, especially from journalists outside of China, has not been a top priority.

Science has tried to interview George Gao, director-general of the Chinese Center for Disease Control and Prevention (CDC), for 2 months. Last week he responded.

Gao oversees 2000 employeesone-fifth the staff size of the U.S. Centers for Disease Control and Preventionand he remains an active researcher himself. In January, he was part of a team that did the first isolation and sequencing of severe acute respiratory syndrome 2 (SARS-CoV-2), the virus that causes COVID-19. He co-authored two widely read papers published in The New England Journal of Medicine (NEJM) that provided some of the first detailed epidemiology and clinical features of the disease, and has published three more papers on COVID-19 in The Lancet.

His team also provided important data to a joint commission between Chinese researchers and a team of international scientists, organized by the World Health Organization (WHO), that wrote a landmark report after touring the country to understand the response to the epidemic.

First trained as a veterinarian, Gao later earned a Ph.D. in biochemistry at the University of Oxford and did postdocs there and at Harvard University, specializing in immunology and virology. His research specializes in viruses that have fragile lipid membranes called envelopesa group that includes SARS-CoV-2and how they enter cells and also move between species.

Gao answered Sciences questions over several days via text, voicemails, and phone conversations. This interview has been edited for brevity and clarity.

George Gao, head of the Chinese Center for Disease Control and Prevention

Q: What can other countries learn from the way China has approached COVID-19?

A: Social distancing is the essential strategy for the control of any infectious diseases, especially if they are respiratory infections. First, we used nonpharmaceutical strategies, because you dont have any specific inhibitors or drugs and you dont have any vaccines. Second, you have to make sure you isolate any cases. Third, close contacts should be in quarantine: We spend a lot of time trying to find all these close contacts, and to make sure they are quarantined and isolated. Fourth, suspend public gatherings. Fifth, restrict movement, which is why you have a lockdown, the cordon sanitaire in French.

Q: The lockdown in China began on 23 January in Wuhan and was expanded to neighboring cities in Hubei province. Other provinces in China had less restrictive shutdowns. How was all of this coordinated, and how important were the supervisors overseeing the efforts in neighborhoods?

A: You have to have understanding and consensus. For that you need very strong leadership, at the local and national level. You need a supervisor and coordinator working with the public very closely. Supervisors need to know who the close contacts are, who the suspected cases are. The supervisors in the community must be very alert. They are key.

Q: What mistakes are other countries making?

A: The big mistake in the U.S. and Europe, in my opinion, is that people arent wearing masks. This virus is transmitted by droplets and close contact. Droplets play a very important roleyouve got to wear a mask, because when you speak, there are always droplets coming out of your mouth. Many people have asymptomatic or presymptomatic infections. If they are wearing face masks, it can prevent droplets that carry the virus from escaping and infecting others.

Q: What about other control measures? China has made aggressive use of thermometers at the entrances to stores, buildings, and public transportation stations, for instance.

A: Yes. Anywhere you go inside in China, there are thermometers. You have to try to take peoples temperatures as often as you can to make sure that whoever has a high fever stays out.

And a really important outstanding question is how stable this virus is in the environment. Because its an enveloped virus, people think its fragile and particularly sensitive to surface temperature or humidity. But from both U.S. results and Chinese studies, it looks like its very resistant to destruction on some surfaces. It may be able to survive in many environments. We need to have science-based answers here.

Q: People who tested positive in Wuhan but only had mild disease were sent into isolation in large facilities and were not allowed to have visits from family. Is this something other countries should consider?

A: Infected people must be isolated. That should happen everywhere. You can only control COVID-19 if you can remove the source of the infection. This is why we built module hospitals and transformed stadiums into hospitals.

Q: There are many questions about the origin of the outbreak in China. Chinese researchers have reported that the earliest case dates back to 1 December 2019. What do you think of the report in the South China Morning Post that says data from the Chinese government show there were cases in November 2019, with the first one on 17 November?

A: There is no solid evidence to say we already had clusters in November. We are trying to better understand the origin.

Q: Wuhan health officials linked a large cluster of cases to the Huanan seafood market and closed it on 1 January. The assumption was that a virus had jumped to humans from an animal sold and possibly butchered at the market. But in your paper in NEJM, which included a retrospective look for cases, you reported that four of the five earliest infected people had no links to the seafood market. Do you think the seafood market was a likely place of origin, or is it a distractionan amplifying factor but not the original source?

A: Thats a very good question. You are working like a detective. From the very beginning, everybody thought the origin was the market. Now, I think the market could be the initial place, or it could be a place where the virus was amplified. So thats a scientific question. There are two possibilities.

Q: China was also criticized for not sharing the viral sequence immediately. The story about a new coronavirus came out in The Wall Street Journal on 8 January; it didnt come from Chinese government scientists. Why not?

A: That was a very good guess from The Wall Street Journal. WHO was informed about the sequence, and I think the time between the article appearing and the official sharing of the sequence was maybe a few hours. I dont think its more than a day.

Q: But a public database of viral sequences later showed that the first one was submitted by Chinese researchers on 5 January. So there were at least 3 days that you must have known that there was a new coronavirus. Its not going to change the course of the epidemic now, but to be honest, something happened about reporting the sequence publicly.

A: I dont think so. We shared the information with scientific colleagues promptly, but this involved public health and we had to wait for policymakers to announce it publicly. You dont want the public to panic, right? And no one in any country could have predicted that the virus would cause a pandemic. This is the first noninfluenza pandemic ever.

Infected people must be isolated. That should happen everywhere.

Q: It wasnt until 20 January that Chinese scientists officially said there was clear evidence of human-to-human transmission. Why do you think epidemiologists in China had so much difficulty seeing that it was occurring?

A: Detailed epidemiological data were not available yet. And we were facing a very crazy and concealed virus from the very beginning. The same is true in Italy, elsewhere in Europe, and the United States: From the very beginning scientists, everybody thought: Well, its just a virus.

Q: Spread in China has dwindled to a crawl, and the new confirmed cases are mainly people entering the country, correct?

A: Yes. At the moment, we dont have any local transmission, but the problem for China now is the imported cases. So many infected travelers are coming into China.

Q: But what will happen when China returns to normal? Do you think enough people have become infected so that herd immunity will keep the virus at bay?

A: We definitely dont have herd immunity yet. But we are waiting for more definitive results from antibody tests that can tell us how many people really have been infected.

Q: So what is the strategy now? Buying time to find effective medicines?

A: Yesour scientists are working on both vaccines and drugs.

Q: Many scientists consider remdesivir to be the most promising drug now being tested. When do you think clinical trials in China of the drug will have data?

A: In April.

Q: Have Chinese scientists developed animal models that you think are robust enough to study pathogenesis and test drugs and vaccines?

A: At the moment, we are using both monkeys and transgenic mice that have ACE2, the human receptor for the virus. The mouse model is widely used in China for drug and vaccine assessment, and I think there are at least a couple papers coming out about the monkey models soon. I can tell you that our monkey model works.

Q: What do you think of President Donald Trump referring to the new coronavirus as the China virus or the Chinese virus?

A: Its definitely not good to call it the Chinese virus. The virus belongs to the Earth. The virus is our common enemynot the enemy of any person or country.

Read more:
Not wearing masks to protect against coronavirus is a 'big mistake,' top Chinese scientist says - Science Magazine

March Madness and the hunt for Double Q Salmon – The Citizen.com

The coronavirus outbreak still has my head spinning. As health officials keenly followed COVID-19, March began with news of the first U.S. death, a man in Washington state. Also, the CDC reported the first possible outbreak at a long-term care facility in Washington.

After a rough February closing, March 1 news reported a stock market surge of 5.1%. The rebound didnt last as economic distress surged as well.

Adjusting to the time change as we began the week of March 9, we wondered what a week with a full moon and a Friday the 13th would bring. We soon saw the coronavirus apprehension snowball.

The sports world turned upside down as various leagues cancelled, postponed or rescheduled their seasons. School systems shut down. Even some May graduations are already cancelled.

As new developments unfolded daily, observing peoples reactions became a study in human behavior. First came denial and disbelief. We lived our lives as if we werent affected, thinking China is a long way from America. Then COVID-19 hit Washington state and steadily spread.

Denial turned to skepticism: The news media is creating hysteria and people are overreacting, or This is a conspiracy with a political agenda, or This whole virus-thing is overblown.

Then skepticism turned to fear as people bombarded stores. Toilet paper turned to gold. Hand-wipes disappeared. As my March 15 birthday approached, I requested fried salmon patties for my special meal. Suddenly, I couldnt find Double Q Pink Salmon as I daily visited several groceries and discovered the canned meat aisles cleared. I struck out.

Fear turned to hysteria as shoppers acted like a blizzard was coming, packing parking lots, standing in lines waiting for stores to open, clearing out key items. It was each man for himself until stores set limits. One customer asked, Did I miss the memo that the world was going to end?

Now folks seem to be coping with this disruption, hoping for this crisis to pass soon and for life to return to normal.

This craziness gives new meaning to March madness and reminds us how uncertain life is. Fear, scarcity and an unknown future trigger a reaction like stockpiling.

Stockpiling is a means of exerting control in a situation that is out of control, said Jon Mueller, professor of psychology at North Central College in Napierville, Illinois. We want to do things to gain control, he said, and hoarding supplies offsets our sense of helplessness.

Chris Elkins, chief of staff at Denison Forum, shared hes having a hard time.

Theres no certainty about how this virus will spread or whom it will impact I have zero control of the stock market, the hoarding or peoples compliance to guidelines. I find this troubling and deeply disturbing.

Nothing in this world is certain, no matter the balance in my checking account or the investments in my retirement plan. Control is an illusion (https://www.denisonforum.org/columns/daily-article/healthcare-providers-are-experiencing-pre-traumatic-stress-disorder-fear-not-for-i-am-with-you/).

The reality is, under normal circumstances, we are NOT in control, even though we want to be. The sooner we accept that reality, the sooner we can lessen our anxiety. How can we live confidently in a world thats going nuts?

First, replace fear with faith. Faith and fear cannot coexist. Either were fearing or were demonstrating faith. Satan uses fear to erode our faith.

In times like these, where do you turn? Asaph found himself in a crisis and wrote, I cried out to God with my voice and He gave me ear. In the day of my trouble I sought the Lord (Psalm 77:1, 2a). Look first to God.

Second, remember Gods presence. Deuteronomy 31:8 reads, And the Lord, He is the One who goes before you. He will be with you. He will not leave you nor forsake you; do not fear nor be dismayed. God is with us in this crisis.

Third, look out for others. Were in this together. Dont fight over toilet paper. Share the wealth. Check on your neighbors, especially the elderly. Remember its not just about you.

Fourth, shine brightly. Believers must let the world see us living unafraid, using good sense, exercising wisdom, but living as people of faith who trust in a God who is bigger than coronavirus.

I finally found my favorite brand, Double Q Salmon, by the way, and got to enjoy my belated birthday treat. And it was delicious!

[David L. Chancey is pastor, Fayettevilles McDonough Road Baptist Church. Currently, the church family is meeting online. Join them on their Facebook page at McDonough Road Baptist Church/MRBC for Bible study at 9:45 Sundays and worship on Facebook Live at 10:55 a.m. Visit them at http://www.mcdonoughroad.org or call 770-460-5423 for more information.]

Continued here:
March Madness and the hunt for Double Q Salmon - The Citizen.com

Together, we will get through this | News, Sports, Jobs – Fort Dodge Messenger

-Submitted photoUnityPoint Health Fort Dodge team members representing therapy, surgical services, acute care and environmental services, give their message to the community. Top row, from left to right: Tammy Pattison, Deanne Cummins-Thiele, Heidi Lennon, Elena Sassman, Amanda Jensen and Dawn Kirkpatrick. Bottom row, from left to right: Judy Haines, Jenna Linder, Amanda Grablin and Brittany Lantz.

-Submitted photoUnityPoint Health Fort Dodge team members representing therapy, surgical services, acute care and environmental services, give their message to the community. Top row, from left to right: Tammy Pattison, Deanne Cummins-Thiele, Heidi Lennon, Elena Sassman, Amanda Jensen and Dawn Kirkpatrick. Bottom row, from left to right: Judy Haines, Jenna Linder, Amanda Grablin and Brittany Lantz.

In light of Webster Countys first COVID-19 case, we want to ensure our community has accurate and factual information.

We are extremely proud of the work that has been done to prepare for the COVID-19 pandemic with our community partners through the Emergency Operations Center (EOC). The EOC has and continues to provide UnityPoint Health Fort Dodge an opportunity to collaborate and prepare with the following agencies:

City of Fort Dodge

Fort Dodge Community School District

Fort Dodge Emergency Management

Fort Dodge Emergency Services

Fort Dodge Fire Department

Greater Fort Dodge Growth Alliance

Fort Dodge Police Department

Iowa Central Community College

Manson Northwest Webster Community Schools

St. Edmond Catholic School

Southeast Valley Community Schools

Webster County Board of Supervisors

Webster County Public Health

Webster County Sheriffs Department

Additionally, UnityPoint Health Fort Dodge regional Incident Command, in partnership with the UnityPoint Health system Incident Command, has been meeting for weeks to prepare for COVID-19. In consultation with our medical directors: Drs. Lincoln Wallace, Michael Willerth, Alex Cathey, Elizabeth Day, Rachel Sokol and David Jones, surge plans for inpatient beds as well as Emergency Department have been developed that will allow us to double our bed capacity. A waiver has also been submitted to the federal government to allow Trinity Regional Medical Center to exceed our 49-bed limit, in order to support the care needed for our community.

The availability of test kits and ventilator capacity have also been hot topics on social media and in the media. We would like to provide some additional information regarding these very important resources.

Test Kits: UnityPoint Health Fort Dodge has test kits available. Our clinicians remain vigilant about following CDC guidelines for testing as related to COVID-19. Like other testing, patients must meet the criteria before a test is ordered.

Ventilators: The quantity of ventilators available in our region has been an area of concern for many. Please know in preparation of COVID-19, the region has significantly increased its ventilator capacity. We will also work together with the UnityPoint Health system and our rural Critical Access Hospital partners for additional support if needed.

We have prepared to the best of our ability. As a community we were given the gift of time to create solid work plans to ensure a coordinated and efficient response to COVID-19, before Webster County experienced its first COVID-19 case.

There is a lot of information available on social media and through regular media channels it can really feel like too much at times. Please be sure you are going to a trusted source for COVID-19 updates and sharing what is only factual. We recommend the following sites for COVID-19 information: Webster County Public Health; Iowa Department of Public Health; Centers for Disease Control; and the World Health Organization. By sharing only accurate and factual information it will help reduce anxiety and ease the minds of our family, friends and neighbors during this time of uncertainty.

Lastly, what we need now is the help of our community to ensure our healthcare resources will allow UnityPoint Health Fort Dodge to continue providing the best care possible. You can help to reduce and potentially prevent the spread of COVID-19 by following some simple recommendations:

Stay home whenever possible

Practice social distancing

Avoid community gatherings limit your activities to essentials, i.e. work, grocery store, etc.

Wash your hands

Words cannot express our deepest gratitude to all our healthcare professionals, first responders, and service workers for their tireless commitment to our community.

Together, we will get through this.

Leah Glasgo is president and CEO of UnityPoint Health Fort Dodge. Michael Willerth is chief medical officer of UnityPoint Health Fort Dodge.

View post:
Together, we will get through this | News, Sports, Jobs - Fort Dodge Messenger

Is the anti-flu drug Avigan effective in treating COVID-19? – Medical News Today

An experimental new study has recently tested the efficacy of favipiravir (Avigan) for treating COVID-19.

Recently, there has been much media speculation around the Japanese anti-flu drug favipiravir (brand name Avigan) being effective against SARS-CoV-2. This is the virus that causes COVID-19.

This is because Chinese officials announced in a press conference that the drug could effectively treat this virus.

Since then, the results of one of the two clinical trials that the Chinese officials cited have become available. We take a look at the findings and explain why people must interpret them with caution.

Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.

Qingxian Cai, of the National Clinical Research Center for Infectious Diseases at The Third Peoples Hospital of Shenzhen in China, is the first author of the paper, which now appears in the journal Engineering.

As Cai and colleagues explain in their paper, the need for effective antiviral agents capable of combating COVID-19 is dire.

In this context, an efficient approach for drug discovery seems to be to test existing antiviral drugs and see whether or not they are suitable for repurposing.

Healthcare professionals have previously used drugs such as ribavirin, interferon, favipiravir, and lopinavir/ritonavir to treat severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome. These are diseases caused by other coronaviruses. However, the efficacy of some of these drugs is questionable, warn the researchers.

That said, past studies that Cai and team cite in their paper have shown that favipiravir, the anti-flu drug, successfully inhibits SARS-Cov-2 in some cultured cells and protects mice against Ebola.

So, the scientists set out to test the results of treating SARS-Cov-2 using favipiravir, and to compare its efficacy with that of lopinavir/ritonavir.

Lopinavir is an HIV inhibitor that emerged as a potential treatment for the SARS outbreak in 2003. Manufacturers often add ritonavir to lopinavir to increase its half life and reduce its side effects.

The recent study was a non-randomized comparison of two treatment regimens across time. Participants were all patients at The Third Peoples Hospital of Shenzhen.

On day one (in early February), one study group comprising 35 people, all of whom had a confirmed diagnosis of COVID-19 and met the trial criteria, including age and illness severity took 1,600 milligrams (mg) of favipiravir twice (in two separate doses), plus inhaled interferon.

On day two and beyond, this group reduced their dosage to 600 mg twice daily, and they kept taking inhaled interferon.

The control group comprised 45 patients admitted in the last week of January. They took lopinavir/ritonavir for 14 days at a dosage of 400 mg, then 100 mg, twice daily, plus the inhaled interferon.

Those who took favipiravir cleared the virus in an average of 4 days. Those in the control group cleared it in 11 days.

The favipiravir group also showed significant improvement in chest imaging compared with the control arm, with an improvement rate of 91.43% versus 62.22%, report the researchers.

Statistical calculations showed that favipiravir was independently associated with faster viral clearance. In addition, fewer adverse reactions were found in the [favipiravir group] than in the control group.

As Cai and colleagues conclude, In this open-label non-randomized control study, [favipiravir] showed significantly better treatment effects on COVID-19 in terms of disease progression and viral clearance.

They add:

[I]f causal, these results should be important information for establishing standard treatment guidelines to combat the SARS-CoV-2 infection.

Although the health characteristics of the people in the two groups were statistically comparable at the start of the study, there were important differences between them that cast some doubt on these results.

For example, more participants in the favipiravir group were younger and leaner and had the treatment sooner after the onset of symptoms. On the other hand, fewer participants in this group had fever, for instance.

Because the study was so small, such minor differences as these can skew the results despite the scientists accounting for these factors in the analysis. In other words, the slightest error could bias the findings.

This small study provides some potentially exciting results, but the lack of randomization, the differences in severity of the disease, the differences in age of the two groups, and the lack of blinding of outcomes to the researchers all cast doubt on the findings.

Well-conducted randomized controlled trials are necessary before doctors can use this drug for this purpose in clinical practice.

For live updates on the latest developments regarding the novel coronavirus and COVID-19, click here.

Here is the original post:
Is the anti-flu drug Avigan effective in treating COVID-19? - Medical News Today

Meme Misleads on Hospital Visits to Children With COVID-19 – FactCheck.org

Quick Take

A viral meme suggests that children hospitalized with COVID-19 in the U.S. and U.K. cant be visited by a parent. Hospital policies have become generally more restrictive, but pediatric patients are still allowed visits by at least one parent.

A meme circulating on social media implores people to stay home in order to reduce the spread of the novel coronavirus. The message its trying to send is right, but the alarmist claims it makes are wrong.

The meme says: [I]f your child gets this virus their going to hospital alone in a van with people they dont know to a room they dont know to be with people they dont know You will be at home without them in their time of need Think about it Stay in.

It was shared on March 24 by a Facebook page called This is England and was then shared by several other British Facebook pages before it began to circulate on American accounts.

We are focusing on one of the claims the implication that there is a mandatory policy to separate parents from children who are hospitalized for COVID-19. That isnt true in either country.

Guidance from the Royal College of Pediatrics and Child Health in the U.K. says:

Many hospitals in the U.K. have eliminated patient visitation, except for children, who are allowed to have a parent or carer visit.

Guidance is similar in the U.S., with details varying from state to state and hospital to hospital.

In New York, which currently has the most cases of COVID-19 in the country, the state Department of Health recommended that hospitals suspend visitation except in cases where the visitor is essential to the care of the patient. One major hospital system, NewYork-Presbyterian, has used that guidance to end visitation, with some exceptions, including for pediatric patients who may have one visitor.

In the state of Washington, which had the first confirmed case in the U.S., the hospitals run by the University of Washington have suspended all regular patient visits. But patients under 18 are allowed to have visits from a parent or guardian.

Similar policies are in effect in other areas, too, including the hospitals of the Ohio State University and the University of Kentucky.

While the novel coronavirus can sicken people of any age, it is worth noting that those most at risk for becoming severely ill and requiring hospitalization are elderly people and those with underlying health conditions.

Between Feb. 12 and March 16, no patients under 19 years old were admitted to an intensive care unit in the U.S. for treatment of COVID-19, according to the Centers for Disease Control and Prevention.

Editors note: FactCheck.org is one of several organizationsworking with Facebookto debunk misinformation shared on social media. Our previous stories can be found here.

World Health Organization. Live from WHO Headquarters coronavirus COVID-19 daily press briefing 25 March 2020. YouTube. 25 Mar 2020.

Royal College of Pediatrics and Child Health. COVID-19 guidance for paediatric services. Last modified 26 Mar 2020.

New York State Department of Health. Health Advisory: COVID-19 Guidance for Hospital OperatorsRegarding Visitation. 18 Mar 2020.

Centers for Disease Control and Prevention. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) United States, February 12March 16, 2020. 26 Mar 2020.

Visit link:
Meme Misleads on Hospital Visits to Children With COVID-19 - FactCheck.org